| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 17 |
| 1 | ATENOLOL | 15 |
| 2 | OMEPRAZOLE MAGNESIUM | 14 |
| 3 | OMEPRAZOLE | 13 |
| 4 | CYCLOPHOSPHAMIDE | 12 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 12 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 12 |
| 7 | PREDNISONE | 12 |
| 8 | METRONIDAZOLE | 11 |
| 9 | SULFAMETHOXAZOLE AND TRIMETHOPRIM | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | 1 | 0.0067 |
| 1 | PALIFERMIN | 1 | 0.0026 |
| 2 | PENTOSTATIN | 2 | 0.0019 |
| 3 | PENTAMIDINE ISETHIONATE | 2 | 0.0016 |
| 4 | ALOSETRON HYDROCHLORIDE | 1 | 0.0012 |
| 5 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 5 | 0.0011 |
| 6 | GEMTUZUMAB OZOGAMICIN | 4 | 0.0011 |
| 7 | NAFCILLIN SODIUM | 1 | 0.0011 |
| 8 | CLOFARABINE | 2 | 0.0009 |
| 9 | VANCOMYCIN HYDROCHLORIDE | 7 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 33 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 29 |
| 2 | Proton Pump Inhibitor [EPC] | 23 |
| 3 | Platinum-based Drug [EPC] | 22 |
| 4 | Alkylating Drug [EPC] | 17 |
| 5 | Loop Diuretic [EPC] | 17 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 16 |
| 7 | beta-Adrenergic Blocker [EPC] | 16 |
| 8 | Benzodiazepine [EPC] | 14 |
| 9 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 1 | CD33-directed Immunoconjugate [EPC] | 3 | 0.0008 |
| 2 | beta Lactamase Inhibitor [EPC] | 3 | 0.0007 |
| 3 | Sulfonamide Antibacterial [EPC] | 2 | 0.0005 |
| 4 | Benzothiazole [EPC] | 1 | 0.0004 |
| 5 | Anthelmintic [EPC] | 1 | 0.0003 |
| 6 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 7 | Nitroimidazole Antimicrobial [EPC] | 11 | 0.0002 |
| 8 | Lipid-based Polyene Antifungal [EPC] | 2 | 0.0002 |
| 9 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |